Organogenesis Holdings Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| ORGANOGENESIS HOLDINGS INC. | |
|---|---|
| By: | /s/ Gary S. Gillheeney, Sr. |
| Gary S. Gillheeney, Sr.Chief Executive Officer, President, and Chair of the Board of Directors | |
| Date: | February 27, 2025 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report has been signed below by the following persons on behalf of the Company and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Gary S. Gillheeney, Sr. | Chief Executive Officer, President and Chair of the Board of Directors (Principal Executive Officer) | February 27, 2025 |
| Gary S. Gillheeney, Sr. | ||
| /s/ David Francisco | Chief Financial Officer (Principal Financial and Accounting Officer) | February 27, 2025 |
| David Francisco | ||
| /s/ Alan A. Ades | Director | February 27, 2025 |
| Alan A. Ades | ||
| /s/ Robert Ades | Director | February 27, 2025 |
| Robert Ades | ||
| /s/ Michael J. Driscoll | Director | February 27, 2025 |
| Michael J. Driscoll | ||
| /s/ Prathyusha Duraibabu | Director | February 27, 2025 |
| Prathyusha Duraibabu | ||
| /s/ David Erani | Director | February 27, 2025 |
| David Erani | ||
| /s/ Jon Giacomin | Director | February 27, 2025 |
| Jon Giacomin | ||
| /s/ Michele Korfin | Director | February 27, 2025 |
| Michele Korfin | ||
| /s/ Arthur S. Leibowitz | Director | February 27, 2025 |
| Arthur S. Leibowitz | ||
| /s/ Garrett Lustig | Director | February 27, 2025 |
| Garrett Lustig | ||
| /s/ Glenn H. Nussdorf | Director | February 27, 2025 |
| Glenn H. Nussdorf | ||
| /s/ Gilberto Quintero | Director | February 27, 2025 |
| Gilberto Quintero | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |
| Reports of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Consolidated Balance Sheets as of December 31, 2024 and 2023 | F-5 |
| Consolidated Statements of Operations and Comprehensive Income for the Years Ended December 31, 2024, 2023, and 2022 | F-6 |
| Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity for the Years Ended December 31, 2024, 2023, and 2022 | F-7 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023, and 2022 | F-8 |
| Notes to Consolidated Financial Statements | F-9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.